Navigation Links
American Academy of Dermatology Issues New Guidelines for the Management of Psoriasis and Psoriatic Arthritis
Date:5/21/2008

Dermatologists hopeful that more patients will benefit from increased

understanding of therapies for psoriasis

SCHAUMBURG, Ill., May 21 /PRNewswire/ -- The American Academy of Dermatology (Academy) has released new guidelines of care for the management of psoriasis and psoriatic arthritis based on an extensive analysis of the highest-quality scientific studies on these serious conditions. An estimated 6-7 million Americans are affected by psoriasis, and the presence of psoriatic arthritis in the general U.S. population has been estimated to affect between 300,000 and 750,000 individuals.

Published in the May issue of the Journal of the American Academy of Dermatology, the new psoriasis and psoriatic guidelines present the latest recommendations for treating patients with mild to severe cases of these conditions. "As a result of the impartial analysis of the most current research, physicians now have evidence-based guidelines which will help enhance the quality of care for patients and ultimately their safety," said dermatologist, C. William Hanke, MD, FAAD, president of the Academy. "The guidelines for psoriasis and psoriatic arthritis, which focus on the use of biologics, are the first phase of the Academy's efforts. The Academy is currently working on the second phase of these guidelines which will provide evidence-based advice for the management of psoriasis with topical therapies, ultraviolet light therapy, and systemic non-biologic therapies for psoriasis."

Psoriasis is a chronic skin condition which usually begins before the age of 35 and is characterized by thick, red, scaly patches that itch and bleed. Although it is a genetic disease, it is not completely understood how it is inherited. However, there are at least eight chromosomes to date that researchers have identified as being linked to the genetic transmission of the disease. In addition, a number of environmental factors play an important role in the deve
'/>"/>

SOURCE American Academy of Dermatology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Health Plan of Michigan Ranked Number One Among Medicaid Health Plans in Michigan for Access to Medications for African Americans
2. Together Rx Access(R) Program Enrolls More Than 1.5 Million Americans Without Prescription Drug Coverage
3. 2008 American Academy of Pediatric Dentistry Annual Session Highlights Emerging Scientific Advancements
4. New Survey Reveals Hispanic-Americans Are Taking Steps to Better Understand and Manage GERD
5. American Heart Association Ranks Americas Most Heart Friendly Cities for Women
6. AUDIO from Medialink, Oral Health America & Philips Sonicare: National Smile Month - Giving Americans Something to Smile About Survey Reveals State of Americans Oral Health
7. American Academy of Pediatrics/American Heart Association Clarification of Statement on Cardiovascular Evaluation and Monitoring of Children and Adolescents With Heart Disease Receiving Medications for ADHD
8. IDM Pharma Announces Presentations at 44th American Society of Clinical Oncology Annual Meeting
9. Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting
10. Statement from Larry Minnix, President & CEO American Association of Homes and Services for the Aging, On the Government Accountability Offices (GAO) Nursing Home Oversight Report
11. American Red Cross Vindicated in J&J Lawsuit

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Biotech firm Replikins Ltd. tod...1N1 virus genomic data. It shows that the lethali...s.d. 4.5) during the virus,s current outbreak in t...his week of 2.0 (s.d. 0.1). The H1N1 infectivity c... Boston (PRWEB) November 27, 2009 -- Bio...
(Date:11/27/2009)... , NEUILLY-SUR-SEINE, France, Nov. 27 /PRNewsw... professional cycling team dedicated to ethical sp...ng champions, announced today that it will become ...itions Optical as a new sponsor of the team. Trans... of adaptive eyewear, offering the most advanced p...
(Date:11/27/2009)... rates to bring unprecedented medical, economic bu...7 (HealthDay News) -- The number of people with di...over the next 25 years, a new study predicts. ,...million people with the disease, up from 23.7 mill...ating people with diabetes will triple, the study ...
(Date:11/27/2009)... Specialist manufacturers who us...s are saving millions of dollars by bringing in te...ss. Increasing numbers of pro-active medical manuf...at the concept stage of their projects, ensuring t...esign processes or potentially outdated technology...
(Date:11/26/2009)...e next 25 years, the number of Americans living wi....7 million in 2009 to 44.1 million in 2034. Over t...riple, rising from $113 billion to $336 billion, e... researchers based at the University of Chicago re... The number of those with diabetes covered by Medi...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
...smart Now the Only Provider to Offer Practice Mana...zes and Types of Mental Health Care Providers, GR...nc.,a leading provider of enterprise-wide software...ale VantageMed,Corporation, a subsidiary of Nighti...
...dings suggest treatment ,holidays, improve quality...(HealthDay News) -- Some men with advanced prostat..., says a study by researchers at the Oregon Health... from the prostate and isn,t affected by the male ...
... COLD SPRING HARBOR, N.Y. Rarely has a book in ...odor Boveris 1914 monograph Concerning the Origin...nd previously almost impossible to track down, the...Concerning the Origin of Malignant Tumours had a ...
...HELL, Wash., Feb. 29 Nastech,Pharmaceutical Compa...ill,host a conference call with investors and secu...m. Eastern time (8:30 a.m. Pacific time) to,discus...901-5259 and international callers should dial (61...
...PHIS, Tenn., Feb. 29 Smith & Nephew,Inc.,s (NYSE:... Business Unit,announced today the appointment of ...ral manager for its business in Asia and Australia...ion, marketing and supply., Durniak,s appointment...
... these side effects are rare and benefits still ou... 29 (HealthDay News) -- Cholesterol-lowering stati...h researchers report. , However, "our series sugge...y Hospital. , Reporting in the March issue of Art...
Other Medicine News:Health News:Netsmart Technologies Acquires Largest Provider of Software for Private Practice Mental Health Providers and Therapists 2Health News:Netsmart Technologies Acquires Largest Provider of Software for Private Practice Mental Health Providers and Therapists 3Health News:Netsmart Technologies Acquires Largest Provider of Software for Private Practice Mental Health Providers and Therapists 4Health News:Chemo Break Benefits Some Men With Prostate Cancer 2Health News:Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, March 3, 2008 2Health News:Smith & Nephew Orthopaedic Reconstruction Global Management Team Announced 2Health News:Smith & Nephew Orthopaedic Reconstruction Global Management Team Announced 3Health News:Smith & Nephew Orthopaedic Reconstruction Global Management Team Announced 4Health News:Cholesterol-Lowering Statins Tied to Tendon Woes 2Health News:Cholesterol-Lowering Statins Tied to Tendon Woes 3
(Date:11/25/2009)...INCETON, N.J., Nov. 25 P... pharmaceutical company committed to discovering, ...t viral infections, reported financial results for...ember 30, 2009 Pharmasset held $58.4 million in ca...,, Pipeline Update and 2009 Highlights ,, ...
(Date:11/25/2009)...GEWATER, N.J., Nov. 25 The FDA gra...avirine) tablets, a non-nucleoside reverse transcr...RTI specifically indicated for use in treatment-ex...ilure with HIV-1 strains resistant to an NNRTI and...al approval is based on 48-week data from two Phas...
(Date:11/25/2009)...SKING RIDGE, N.J., Nov. 25 Regado ...development of antithrombotic aptamers with active...CEO and President, will be presenting at the Piper... New York Palace Hotel in New York City. Dr. Mazz...Tuesday, December 1 and will include an overview o...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Electrocardiogram Blip Signals Heart Trouble 49820 1Electrocardiogram Blip Signals Heart Trouble 49820 2Electrocardiogram Blip Signals Heart Trouble 49820 3Connextions Inc Strengthens Technology Capabilities with Addition of Highly Regarded IT Executive 49816 1Connextions Inc Strengthens Technology Capabilities with Addition of Highly Regarded IT Executive 49816 2Connextions Inc Strengthens Technology Capabilities with Addition of Highly Regarded IT Executive 49816 3Children 26apos 3Bs National Medical Center Honors The Children 26apos 3Bs Cancer Foundation for Commitment to Area Kids 49812 1Children 26apos 3Bs National Medical Center Honors The Children 26apos 3Bs Cancer Foundation for Commitment to Area Kids 49812 2Children 26apos 3Bs National Medical Center Honors The Children 26apos 3Bs Cancer Foundation for Commitment to Area Kids 49812 3
...ppoints Director, Clinical Operations and Manager,...tar LLC, (Cellectar), a,privately-held radiopharma...ts to detect, treat and monitor human cancers, tod...rector, Clinical Operations and LisaAnn,Trembath a...eflect the,advancement of the company,s lead produ...
...NCETON, N.J., Oct. 3 Pharmasset, Inc.,(Nasdaq: V...7128 in,combination with Pegasys (pegylated interf...nt-naive patients chronically infected with hepati...f PSI-6130, an oral cytidine,nucleoside analog pol...hrough Pharmasset,s collaboration with Roche. The ...
Other Medicine Technology:Cellectar Expands Clinical Management Team 2Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C 2Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C 3Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C 4Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C 5
Sterile Coil Packed Suction Catheters with SAFE-T-VAC Valve
Tracheal Suction Plastic Catheters
Aviso A/B
... an affordable full-field, autoperimeter that incl...by at least 40%. It has a small footprint and is r...and easy two-button operation making it not only p...D 400 FT is the workhorse of the Paradigm family o...
Medicine Products: